Yu Kyung Cho

INTRODUCTION: Zastaprazan is a novel potassium-competitive acid blocker (P-CAB) with fast onset and prolonged duration. This study aims to assess the efficacy and safety of zastaprazan compared to esomeprazole in patient with erosive esophagitis…

BACKGROUND AND AIMS: Helicobacter pylori (H. pylori) eradication in patients with gastric ulcers is known to reduce the risk of gastric cancer. However, the impact of eradication therapy on the occurrence of gastric cancer is not well known in these patients, especially in the elderly…